Skip to main content

Advertisement

SpringerLink
Log in

Insights into the relationships between diabetes, prediabetes, and cancer

  • Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Diabetes mellitus and cancer are two growing health problems. They have in common many modifiable risk factors including sex, age, obesity, physical activity, diet, alcohol, and smoking, and have a long latency before overtly manifesting. Patients with diabetes experience a roughly 20–25% higher cancer incidence compared to individuals without diabetes, and it depends on cancer site. Moreover, patients with diabetes who further develop cancer have increased early and late mortality in comparison with cancer patients without diabetes. Prediabetes and metabolic syndrome are also related to an increased risk of developing and die from cancer. Possible mechanisms linking diabetes and prediabetes with cancer include hyperglycemia (endogenous or exogenous), hyperinsulinemia, and alterations of insulin-like growth factor system, chronic subclinical inflammation, abnormalities in sex hormone metabolism, and adipokines. It becomes crucial to define the right orientation of the associations between diabetes and cancer in order to identify the modifiable pathogenic mechanisms. The common soil hypothesis claims that prediabetes and diabetes, as well as metabolic syndrome, may be considered a surrogate sign for dietary risk factors of cancer. The clepsydra of foods may help choose foods associated with healthy benefit while avoiding foods associated with harm, including cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, Belgium: International Diabetes Federation, (2015). http://www.diabetesatlas.org

  2. World Health Organization (WHO), International Agency for Research on Cancer (IARC)—GLOBOCAN 2012 and Cancer fact sheets

  3. World Health Organization (WHO), Cancer fact sheet N° 97 Updated February 2015

  4. E.W. Gregg, X. Zhuo, Y.J. Cheng, A.L. Albright, K.M. Narayan, T.J. Thompson, Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modeling study. Lancet Diabetes Endocrinol. 2, 867–874 (2014)

    Article  PubMed  Google Scholar 

  5. P. Vineis, C.P. Wild, Global cancer patterns: causes and prevention. Lancet 383, 549–557 (2014)

    Article  PubMed  Google Scholar 

  6. M. Arnold, N. Pandeya, G. Byrnes et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 16, 36–46 (2015)

    Article  PubMed  Google Scholar 

  7. S.A. Tanumihardjo, C. Anderson, M. Kaufer-Horwitz et al. Poverty, obesity, and malnutrition: an international perspective recognizing the paradox. J. Am. Diet. Assoc. 107, 1966–1972 (2007)

    Article  PubMed  Google Scholar 

  8. E. Giovannucci, D.M. Harlan, M.C. Archer et al. Diabetes and cancer: a consensus report. Diabetes Care 33, 1674–1685 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  9. WHO. Global status report on non-communicable diseases 2014. pp 1–141. http://www.who.int/chp/ncd_global_status_report/en/

  10. K. Esposito, F. Ciardiello, D. Giugliano, Unhealthy diets: a common soil for the association of metabolic syndrome and cancer. Endocrine 46, 39–42 (2014)

    Article  CAS  PubMed  Google Scholar 

  11. K. Ranc, M.E. Jørgensen, S. Friis, B. Carstensen, Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia 57(5), 927–934 (2014)

    Article  CAS  PubMed  Google Scholar 

  12. A. Renehan, U. Smith, M.S. Kirkman, Linking diabetes and cancer: a consensus on complexity. Lancet 375(9733), 2201–2 (2010).

    Article  PubMed  Google Scholar 

  13. S.M. Bluethmann, A.B. Mariotto, J.H. Rowland, Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol. Biomarkers Prev. 25(7), 1029–1036 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  14. E.C. de Haas, S.F. Oosting, J.D. Lefrandt et al. The metabolic syndrome in cancer survivors. Lancet Oncol. 11, 193–203 (2010)

    Article  CAS  PubMed  Google Scholar 

  15. A.J. Redig, H.G. Munshi, Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am. J. Med. 123, 87 (2010). e1–87.e6

    Article  PubMed  PubMed Central  Google Scholar 

  16. S.C. Darby, M. Ewertz, P. McGale et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368, 987–998 (2013)

    Article  CAS  PubMed  Google Scholar 

  17. T. Tuffier, Diabete et neoplasmes. Arch. Gen. de Med. 7, 129–140 (1988)

    Google Scholar 

  18. Y. Shi, F.B. Hu, The global implications of diabetes and cancer. Lancet 383(9933), 1947–1948 (2014). 7

    Article  PubMed  Google Scholar 

  19. I.C. Lega, A.S. Wilton, P.C. Austin et al. The temporal relationship between diabetes and cancer. Cancer. 17, 2731–2738 (2016)

  20. Y. Handelsman, D. Leroith, Z.T. Bloomgarden et al. Diabetes and cancer—an AACE/ACE consensus statement. Endocr. Pract. 19(4), 675–693 (2013)

    Article  PubMed  Google Scholar 

  21. A. Satija, D. Spiegelman, E. Giovannucci, F.B. Hu, Type 2 diabetes and risk of cancer. BMJ 2, 350 (2015). g7707

    Google Scholar 

  22. C. De Nunzio, A. Tubaro, Prostate cancer: diabetes and prostate cancer - an open debate. Nat. Rev. Urol. 10, 12–14 (2013)

    Article  PubMed  Google Scholar 

  23. D. Bansal, A. Bhansali, G. Kapil, K. Undela, P. Tiwari, Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis. 16, 151–158 (2013). S1

    Article  CAS  PubMed  Google Scholar 

  24. K.K. Tsilidis, N.E. Allen, P.N. Appleby et al. Diabetes mellitus and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Int. J. Cancer 136, 372–381 (2015)

    Article  CAS  PubMed  Google Scholar 

  25. C.H. Tseng, Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 34, 616–621 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  26. Q. Li, S. Kuriyama, M. Kakizaki et al. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki cohort study. Cancer Causes Control 21, 1025–1032 (2010)

    Article  PubMed  Google Scholar 

  27. L. Bensimon, H. Yin, S. Suissa, M.N. Pollak, L. Azoulay, Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 25, 329–338 (2014)

    Article  PubMed  Google Scholar 

  28. S.R. Seshasai, S. Kaptoge, A. Thompson et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364, 829–841 (2011)

    Article  CAS  Google Scholar 

  29. R. Dankner, P. Boffetta, R.D. Balicer et al. Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults. Am. J. Epidemiol. 183(12), 1098–1106 (2016). 15

    Article  PubMed  Google Scholar 

  30. K.K. Tsilidis, J.C. Kasimis, D.S. Lopez, Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 2, 350 (2015). g7607

    Google Scholar 

  31. A.G. Tabak, M. Jokela, T.N. Akbaraly et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373, 2215–2221 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. E. Giovannucci, D. Michaud, The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132, 2208–2225 (2007)

    Article  CAS  PubMed  Google Scholar 

  33. J.A. Johnson, S.L. Bowker, Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54, 25–31 (2011)

    Article  CAS  PubMed  Google Scholar 

  34. B.B. Barone, H.C. Yeh, C.F. Snyder et al. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 33, 931–939 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  35. B.B. Barone, H.C. Yeh, C.F. Snyder et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300, 2754–2764 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. A.G. Renehan, H.C. Yeh, J.A. Johnson et al. Diabetes and cancer evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 55, 1619–1632 (2012)

    Article  CAS  PubMed  Google Scholar 

  37. J.M. Baena-Díez, J. Peñafiel, I. Subirana et al. Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Diabetes Care. 11, 1987–1995 (2016)

  38. M. Tancredi, A. Rosengren, A.M. Svensson et al. Excess mortality among persons with type 2 diabetes. N. Engl. J. Med. 373, 1720–1732 (2015)

    Article  CAS  PubMed  Google Scholar 

  39. A. Rawshani, A.M. Svensson, B. Zethelius et al. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes. JAMA Intern. Med. 176(8), 1146–1154 (2016). 1

    Article  PubMed  Google Scholar 

  40. B. Carstensen, S.H. Read, S. Friis et al. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia 59(5), 980–988 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. A. Guilherme, J.V. Virbasius, V. Puri, M.P. Czech, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 9, 367–377 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. I.J. Neeland, A.T. Turer, C.L. Ayers et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308, 1150–1159 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. K. Bhaskaran, I. Douglas, H. Forbes et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 384(9945), 755–765 (2014). 30

    Article  PubMed  PubMed Central  Google Scholar 

  44. K.G.M.M. Alberti, R.H. Eckel, S.M. Grundy et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009)

    Article  CAS  PubMed  Google Scholar 

  45. X. Yang, G.T.C. Ko, W.Y. So et al. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes 59, 1254–1260 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. J.C. de Beer, L. Liebenberg, Does cancer risk increase with HbA1c, independent of diabetes? Br. J. Cancer 110(9), 2361–8 (2014). 29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. C. Hope, A. Robertshaw, K.L. Cheung et al. Relationship between HbA1c and cancer in people with or without diabetes: a systematic review. Diabet. Med. 8, 1013–1025 (2016)

  48. R. Vigneri, I.D. Goldfine, L. Frittitta, Insulin, insulin receptors, and cancer. J. Endocrinol. Invest. 12, 1365–1376 (2016)

  49. NCD Risk Factor Collaboration (NCD-RisC), Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 387, 1377–1396 (2016)

    Article  Google Scholar 

  50. B. Lauby-Secretan, C. Scoccianti, D. Loomis et al. Body Fatness and Cancer—Viewpoint of the IARC Working Group. N. Engl. J. Med. 375(8), 794–798 (2016). 25

    Article  PubMed  PubMed Central  Google Scholar 

  51. P.T. Campbell, Obesity: a certain and avoidable cause of cancer. Lancet 384(9945), 727–8 (2014). 30

    Article  PubMed  Google Scholar 

  52. M. Arnold, M. Leitzmann, H. Freisling et al. Obesity and cancer: an update of the global impact. Cancer Epidemiol. 41, 8–15 (2016)

    Article  PubMed  Google Scholar 

  53. International Agency for Research on Cancer. IARC handbooks of cancer prevention: weight control and physical activity. (IARC Press, Lyon), (2002). Vol. 6

    Google Scholar 

  54. A.G. Renehan, M. Tyson, M. Egger et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569–78 (2008)

    Article  PubMed  Google Scholar 

  55. N.M. Iyengar, C.A. Hudis, A.J. Dannenberg, Obesity and cancer: local and systemic mechanisms. Annu. Rev. Med. 66, 297–309 (2015)

    Article  CAS  PubMed  Google Scholar 

  56. S.D. Hursting, J. Digiovanni, A.J. Dannenberg et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev. Res. 5, 1260–1272 (2012)

    Article  CAS  Google Scholar 

  57. N. Parekh, Y. Lin, R.B. Hayes et al. Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. Cancer Causes Control 21(4), 631–642 (2010)

    Article  PubMed  Google Scholar 

  58. M.N. Pollak, E.S. Schernhammer, S.E. Hankinson, Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4, 505–518 (2004)

    Article  CAS  PubMed  Google Scholar 

  59. K.K. Wong, J.A. Engelman, L.C. Cantley, Targeting the PI3K signaling pathway in cancer. Curr. Opin. Genet. Dev. 20, 87–90 (2010)

    Article  CAS  PubMed  Google Scholar 

  60. R. Zoncu, A. Efeyan, D.M. Sabatini, mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21–35 (2011)

    Article  CAS  PubMed  Google Scholar 

  61. E. Barrett-Connor, K.T. Khaw, S.S. Yen, Endogenous sex hormone levels in older adult men with diabetes mellitus. Am. J. Epidemiol. 132, 895–901 (1990)

    Article  CAS  PubMed  Google Scholar 

  62. D. Housa, J. Housova, Z. Vernerova, M. Haluzik, Adipocytokines and cancer. Physiol. Res. 55, 233–244 (2006)

    CAS  PubMed  Google Scholar 

  63. A. Mantovani, P. Allavena, A. Sica, F. Balkwill, Cancer-related inflammation. Nature 454, 436–444 (2008)

    Article  CAS  PubMed  Google Scholar 

  64. Y. Huang, X. Cai, M. Qiu et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 57, 2261–2269 (2014)

    Article  CAS  PubMed  Google Scholar 

  65. R.A. DeFronzo, M. Abdul-Ghani, Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol. 108, 3B–24B (2011)

    Article  CAS  PubMed  Google Scholar 

  66. M. Buysschaert, J.L. Medina, M. Bergman, A. Shah, J. Lonier, Prediabetes and associated disorders. Endocrine 48(2), 371–393 (2015)

    Article  CAS  PubMed  Google Scholar 

  67. O. Tabak, R. Gelisgen, H. Erman et al. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin. Invest. Med. 34, E163–E171 (2011)

    Article  CAS  PubMed  Google Scholar 

  68. C.S. Pereira, P. Molz, R.P. Palazzo et al. DNA damage and cytotoxicity in adult subjects with prediabetes. Mutat. Res. 753, 76–81 (2013)

    Article  CAS  PubMed  Google Scholar 

  69. M.G. Vander Heiden, L.C. Cantley, C.B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009)

    Article  CAS  Google Scholar 

  70. P. Stattin, O. Björ, P. Ferrari et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care 30, 561–567 (2007)

    Article  PubMed  Google Scholar 

  71. M. Iwatsuki, K. Mimori, T. Yokobori et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 101, 293–299 (2010)

    Article  CAS  PubMed  Google Scholar 

  72. X.H. Zhou, Q. Qiao, B. Zethelius et al. Diabetes, prediabetes and cancer mortality. Diabetologia 53, 1867–1876 (2010)

    Article  CAS  PubMed  Google Scholar 

  73. S. Gao, A. Li, F. Liu et al. NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell 24, 725–737 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. D. Giugliano, M.I. Maiorino, K. Esposito, Linking prediabetes and cancer: a complex issue. Diabetologia 58(1), 201–202 (2015)

    Article  PubMed  Google Scholar 

  75. K.-H. Wagner, H. Brath, A global view on the development of non communicable diseases. Prev. Med. 54(suppl), S38–S41 (2012)

    Article  PubMed  Google Scholar 

  76. M. Aguilar, T. Bhuket, S. Torres et al. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 313(19), 1973–1974 (2015). 19

    Article  CAS  PubMed  Google Scholar 

  77. K. Esposito, A. Capuano, D. Giugliano, Metabolic syndrome and cancer: holistic or reductionist? Endocrine 45(3), 362–364 (2014)

    Article  CAS  PubMed  Google Scholar 

  78. K. Esposito, P. Chiodini, A. Capuano et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause 20(12), 1301–1309 (2013)

    Article  PubMed  Google Scholar 

  79. K. Esposito, P. Chiodini, A. Capuano et al. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine 45(1), 28–36 (2014)

    Article  CAS  PubMed  Google Scholar 

  80. J.R. Jaggers, X. Sui, S.P. Hooker, M.J. LaMonte et al. Metabolic syndrome and risk of cancer mortality in men. Eur. J. Cancer 45, 1831–1838 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. J.R. Zhou, G.L. Blackburn, W.A. Walker, Symposium introduction: metabolic syndrome and the onset of cancer. Am. J. Clin. Nutr. 86, s817–s819 (2007)

    Article  PubMed  Google Scholar 

  82. K. Esposito, P. Chiodini, A. Colao et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35, 2402–2411 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

  83. J.L. Harding, M. Sooriyakumaran, K.J. Anstey et al. Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts. J. Hypertens. 34(1), 149–155 (2016)

    Article  CAS  PubMed  Google Scholar 

  84. W.H. Chow, G. Gridley, J.F. Fraumani Jr, B. Jarvholm, Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med. 343, 1305–1311 (2000)

    Article  CAS  PubMed  Google Scholar 

  85. N.J. Kocher, C. Rjepaj, H. Robyak et al. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer. World J. Urol. (2016). doi:10.1007/s00345-016-1850-2

  86. N. Hayashi, M. Matsushima, T. Yamamoto et al. The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years. BJU Int. 109(4), 515–519 (2012)

    Article  PubMed  Google Scholar 

  87. H. Jafri, A.A. Alsheikh-Ali, R.H. Karas, Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipidaltering therapy. J. Am. Coll. Cardiol. 55, 2846–2854 (2010)

    Article  CAS  PubMed  Google Scholar 

  88. M. Ezzati, E. Riboli, Behavioral and dietary risk factors for noncommunicable diseases. N. Engl. J. Med. 369, 954–964 (2013)

    Article  CAS  PubMed  Google Scholar 

  89. W.E. Hardman, Diet components can suppress inflammation and reduce cancer risk. Nutr. Res. Pract. 8(3), 233–240 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. C. Micucci, D. Valli, G. Matacchione, A. Catalano, Current perspectives between metabolic syndrome and cancer. Oncotarget. 25, 38959–38972 (2016)

  91. P.C. Calder, N. Ahluwalia, F. Brouns et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106(Suppl 3), S5–78 (2011)

    Article  CAS  PubMed  Google Scholar 

  92. S.I. Grivennikov, F.R. Greten, N. Karin, Immunity, inflammation, and cancer. Cell 140, 883–899 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. F.E. Deng, N. Shivappa, Y. Tang et al. Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: findings from NHANES III. Eur. J. Nutr. (2016). doi:10.1007/s00394-016-1158-4

  94. American Cancer Society. Cancer Facts and Figures 2012. (American Cancer Society, Atlanta, GA), (2012)

    Google Scholar 

  95. R. Doll, R. Peto, The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66, 1191–1308 (1981)

    Article  CAS  PubMed  Google Scholar 

  96. K. Esposito, D. Giugliano, Healthy lifestyle for metabolic health: no more excuse! Endocrine 46(2), 176–178 (2014)

    Article  CAS  PubMed  Google Scholar 

  97. P.C. Hallal, L.B. Andersen, F.C. Bull, R. Guthold, W. Haskell, U. Ekelund, Lancet Physical Activity Series Working Group, Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380(9838), 247–257 (2012)

    Article  PubMed  Google Scholar 

  98. S.C. Moore, I.M. Lee, E. Weiderpass et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern. Med. 176(6), 816–825 (2016). 1

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolic Diseases, Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, University of Campania “L. Vanvitelli”, Piazza L. Miraglia n° 2, 80138, Naples, Italy

    Lorenzo Scappaticcio, Maria Ida Maiorino, Giuseppe Bellastella & Dario Giugliano

  2. Diabetes Unit, Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, University of Campania “L. Vanvitelli”, Piazza L. Miraglia n° 2, 80138, Naples, Italy

    Katherine Esposito

Authors
  1. Lorenzo Scappaticcio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Ida Maiorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Bellastella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dario Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katherine Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katherine Esposito.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approvement

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scappaticcio, L., Maiorino, M.I., Bellastella, G. et al. Insights into the relationships between diabetes, prediabetes, and cancer. Endocrine 56, 231–239 (2017). https://doi.org/10.1007/s12020-016-1216-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1216-y

Keywords

Search

Navigation